Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation

被引:9
作者
Zhang, Yan [1 ]
Zhang, Xue-Ying [2 ]
Shi, Shan-Rui [2 ]
Ma, Chao-Nan [2 ]
Lin, Yun-Peng [3 ]
Song, Wen-Gang [4 ,5 ]
Guo, Shou-Dong [2 ]
机构
[1] Guiqian Int Gen Hosp, Dept Endocrinol & Metab, Guiyang, Peoples R China
[2] Shandong Second Med Univ, Inst Lipid Metab & Atherosclerosis, Sch Pharm, Weifang, Peoples R China
[3] Qixia Tradit Chinese Med Hosp Shandong Prov, Dept Gen Surg, Yantai, Peoples R China
[4] Shandong First Med Univ, Affiliated Hosp 1, Shandong Prov Key Lab Rheumat Dis & Translat Med, Jinan, Peoples R China
[5] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2024年 / 11卷
基金
中国国家自然科学基金;
关键词
PPAR alpha; PPAR beta; PPAR gamma; lipid metabolism; inflammation; cardiovascular disease; CUCUMBER ACAUDINA-MOLPADIOIDES; NF-KAPPA-B; CHOLESTEROL EFFLUX; OXIDATIVE STRESS; GENE-EXPRESSION; HUMAN MONOCYTES; RECEPTOR; GAMMA; ACTIVATION; ALPHA;
D O I
10.3389/fcvm.2024.1372055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammation and dyslipidemia are critical inducing factors of atherosclerosis. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors and control the expression of multiple genes that are involved in lipid metabolism and inflammatory responses. However, synthesized PPAR agonists exhibit contrary therapeutic effects and various side effects in atherosclerosis therapy. Natural products are structural diversity and have a good safety. Recent studies find that natural herbs and compounds exhibit attractive therapeutic effects on atherosclerosis by alleviating hyperlipidemia and inflammation through modulation of PPARs. Importantly, the preparation of natural products generally causes significantly lower environmental pollution compared to that of synthesized chemical compounds. Therefore, it is interesting to discover novel PPAR modulator and develop alternative strategies for atherosclerosis therapy based on natural herbs and compounds. This article reviews recent findings, mainly from the year of 2020 to present, about the roles of natural herbs and compounds in regulation of PPARs and their therapeutic effects on atherosclerosis. This article provides alternative strategies and theoretical basis for atherosclerosis therapy using natural herbs and compounds by targeting PPARs, and offers valuable information for researchers that are interested in developing novel PPAR modulators.
引用
收藏
页数:18
相关论文
共 224 条
  • [11] PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
    Bouhlel, M. Amine
    Derudas, Bruno
    Rigamonti, Elena
    Dievart, Rebecca
    Brozek, John
    Haulon, Stephan
    Zawadzki, Christophe
    Jude, Brigitte
    Torpier, Gerard
    Marx, Nikolaus
    Staels, Bart
    Chinetti-Gbaguidi, Giulia
    [J]. CELL METABOLISM, 2007, 6 (02) : 137 - 143
  • [12] Epigallocatechin gallate decreases plasma triglyceride, blood pressure, and serum kisspeptin in obese human subjects
    Chatree, Saimai
    Sitticharoon, Chantacha
    Maikaew, Pailin
    Pongwattanapakin, Kitchaya
    Keadkraichaiwat, Issarawan
    Churintaraphan, Malika
    Sripong, Chanakarn
    Sririwichitchai, Rungnapa
    Tapechum, Sompol
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (02) : 163 - 176
  • [13] The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges
    Cheang, Wai San
    Tian, Xiao Yu
    Wong, Wing Tak
    Huang, Yu
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (23) : 5512 - 5522
  • [14] Chen JJ, 2019, FOOD FUNCT, V10, P2417, DOI [10.1039/c8fo01089g, 10.1039/C8FO01089G]
  • [15] Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine
    Chen, Kuan-Chung
    Chang, Su-Sen
    Huang, Hung-Jin
    Lin, Tu-Liang
    Wu, Yong-Jiang
    Chen, Calvin Yu-Chian
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2012, 30 (06) : 662 - 683
  • [16] Diosgenin attenuates nonalcoholic hepatic steatosis through the hepatic FXR-SHP-SREBP1C/PPARα/CD36 pathway
    Chen, Suwen
    Sun, Shangwen
    Feng, Yanan
    Li, Xiu
    Yin, Guoliang
    Liang, Pengpeng
    Yu, Wenfei
    Meng, Decheng
    Zhang, Xin
    Liu, Hongshuai
    Zhang, Fengxia
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 952
  • [17] Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development
    Chen, Ziqi
    Liu, Fang
    Zheng, Nanxin
    Guo, Meng
    Bao, Leilei
    Zhan, Yangyang
    Zhang, Mingjian
    Zhao, Yuanyu
    Guo, Wenyuan
    Ding, Guoshan
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 285 - 293
  • [18] Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats
    Cheng, Bin
    Zhou, Ai-Zhen
    Ge, Wen
    Yao, Xiao-Min
    Wang, Juan
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [19] PPARβ in macrophages and atherosclerosis
    Chinetti-Gbaguidi, G.
    Staels, B.
    [J]. BIOCHIMIE, 2017, 136 : 59 - 64
  • [20] Association between medication adherence and cardiovascular outcomes among acute coronary syndrome patients
    Chinwong, Surarong
    Doungsong, Kodchawan
    Channaina, Preeyarat
    Phrommintikul, Arintaya
    Chinwong, Dujrudee
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (09) : 1631 - 1635